Name

Copner Biotech

Legal name

Copner Biotech Ltd.

Website

https://copnerbiotech.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Biofabrication Equipment

NAICS

Plastics Material and Resin Manufacturing (325211)

SIC

Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (2820), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioprinting & Biofabrication Systems (Tissue/Cell Printing Hardware) (IMAAAAAG)

Keywords

• 3D cell culture
• Bioprinting technology
• Tissue engineering
• Cell culture scaffolds
• Biofabrication equipment

Headquarters

HQ city

Ebbw Vale

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. 3D Cell Culture Scaffolds Sales: Sale of 3D PETG Cell Culture Scaffolds with oxygen and nutrient gradients. Available off-the-shelf through distributors or as bespoke designs. Scaffolds provide heterogenous porosity for cell infiltration and growth.
2. Bioprinter Sales (GRAPE S1, GRAPE S1 4D): Sale of 3D and 4D Extrusion Bioprinters. GRAPE S1 is the entry bioprinter; GRAPE S1 4D is the flagship model with microfluidic deposition, multi-temperature zones, and cleanroom environment.
3. GRAPE M1 Software: Bundled with GRAPE bioprinter purchase or available as standalone product through official distributors. Outputs 3D models in GRAPE and STL formats.
4. Bespoke 3D Scaffold Design Services: Team of modellers available to assist in creating bespoke 3D Cell Culture Scaffolds to exacting requirements. Uses bespoke Bio Scaffold modelling software.
5. Technology Licensing: Patented technology available for licence on mutually agreeable terms, with necessary technical support to help businesses make full use of those rights. Includes Bio-scaffold, additive manufacturing, GRAPE data format, heating/cooling control, assisted bioprinting, and component mixing patents.

Go-to-market motion2 records

Distribution channels7 records

Marketing channels6 records

Core offering

Copner Biotech develops, manufactures and sells 3D PETG cell culture scaffolds and proprietary GRAPE S1/GRAPE S1 4D extrusion bioprinters for academic and biotechnology research. The company also offers bespoke 3D scaffold modelling services and licenses its patented GRAPE biofabrication technology on mutually agreeable terms.

Product overview

Copner Biotech offers a unified portfolio of 3D cell culture and biofabrication products centered on proprietary GRAPE technology. The product line comprises: GRAPE S1 (entry-level 3D extrusion bioprinter) and GRAPE S1 4D (flagship 4D extrusion bioprinter with microfluidic technology and multi-zone temperature control); 3D PETG Cell Culture Scaffolds with heterogenous porosity for cell microenvironment research; and GRAPE M1 3D modelling software that outputs in the proprietary GRAPE format as well as STL for third-party printer compatibility. The GRAPE 3D modelling data format underpins the entire product ecosystem, enabling precise, batch-consistent biofabrication.

Differentiator

Problem solved

Functional benefit

Brands

• GRAPE: Proprietary 3D modelling data format - Graphical Rectangular Actual Positional Encoding - specifically developed for biofabrication. Registered trademark in UK, EU, and USA.
• Renderable Biofabrication

Products and services

• 3D PETG Cell Culture Scaffolds 3D cell culture scaffolds based on concentric shape constructs providing heterogenous pore size distribution (10–1000 microns) with oxygen and nutrient gradients to maximise cell growth in physiologically relevant in vitro conditions. Available off-the-shelf through distributors or as bespoke designs for universities, research institutions, and biotech companies.
• GRAPE S1 3D Extrusion Bioprinter Entry-level 3D extrusion bioprinter with high precision printing powered by GRAPE control software, bundled with GRAPE 3D modelling software and a remote control application. Targeted at researchers beginning their biofabrication journey.
• GRAPE S1 4D Extrusion Bioprinter Flagship 4D extrusion bioprinter (450mm height, 385mm width, 350mm depth) employing microfluidic droplet deposition with multi-zone temperature control and a cleanroom-type environment. Print nozzle diameters range from 0.25mm to 0.05mm with positional delta movement resolution of 0.01mm; does not require external compressors or laboratory modifications.
• GRAPE M1 3D Modelling Software Next-generation 3D modelling software that outputs files in both proprietary GRAPE and STL formats, enabling precise design of complex microarchitectures for 3D cell culture and tissue engineering. Available bundled with GRAPE bioprinter purchases or as a standalone product through official distributors.
• Bespoke 3D Scaffold Design Services Team of in-house modellers assist customers in creating bespoke 3D cell culture scaffolds to exacting requirements using bespoke Bio Scaffold modelling software. Deliverables include printable STL models for conventional 3D printers and CBL models for Copner Biotech's proprietary bioprinters.

Quantifiable outcome

• Pore sizes can range from 10 to 1000 microns with interconnects between 50-400 microns
• +2 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

15 partnerships are on record, tiered core and minor.

• University of HullcoreStrategic or Co-development Partner · 1 April 2026Delivery of biofabrication seminar together with GRAPE S1 3D bioprinter for researchers to develop novel pancreatic models.
• Newcastle University and Northumbria UniversitycoreStrategic or Co-development Partner · 1 March 2026Collaboration to develop novel in vitro models of cartilage funded by NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research). Delivery of GRAPE S1 4D bioprinter and seminar.
• Northampton University and Loughborough UniversitycoreStrategic or Co-development Partner · 1 November 2025Collaborative biofabrication research programme to expand state-of-the-art 4D bioprinting technology for biomedical research. Building on sarcoma research, deploying GRAPE S1 4D for dynamic in-vitro models for immune disorders, cancer, and therapeutic testing.
• Glasgow UniversitycoreStrategic or Co-development Partner · 1 June 2025Collaboration on cutting edge research into treatments for Prostate Cancer. Development of novel bioprinted prostate cancer models for drug testing with Dr Syer Choon Lim.
• Beijing International Science and Technology Cooperation Center / UK Department of Business and TrademinorGTM or Marketing Partner · 1 December 2024CEO Jordan Copner showcased Next Generation 3D Cell Culture and 4D Bioprinting Technology at China-UK Medical Technology Promotion Conference in Beijing. Co-organized by Beijing International Science and Technology Cooperation Center, Capital Science and Technology Service Industry Association, and UK Department of Business and Trade Life Sciences and Healthcare Department.
• Northampton UniversitycoreStrategic or Co-development Partner · 1 November 2024Contract to supply GRAPE S1 3D Bioprinter bundled with 3D GRAPE M1 Modelling software and 3D PETG Cell Culture Scaffolds to Professor Karen Anthony's team.
• Manchester Institute of BiotechnologyminorStrategic or Co-development Partner · 1 September 2024Attendance at MIB Conference on In Vitro Cell Culture Models: Moving towards animal free. CTO and CFO presented biotechnology and provided free samples of award-winning animal free 3D PETG Cell Culture Scaffolds.
• CliniSciencescoreChannel Partner/ Reseller/ Distributor · 1 August 2024Partnership with leading European distributor to expand distribution network in United Kingdom and Europe for 3D Cell Culture Scaffolds.
• Custom SciencecoreChannel Partner/ Reseller/ Distributor · 1 July 2024Partnership to introduce 3D Cell Culture technologies into Australia.
• Aston UniversitycoreStrategic or Co-development Partner · 1 April 2024Supply of GRAPE S1 4D Bioprinter and 3D GRAPE M1 Modelling software for cultivated meat research. Collaboration with Louis Hutchings and Aston University on cutting edge R&D.
• Henry Royce InstituteminorStrategic or Co-development Partner · 1 March 2024Invited to participate in Biosculpt UK-India Conference hosted by Indian Institute of Science (IISc) Bangalore. UK's National Institute for Advanced Materials Research and Innovation.
• ISOGEN LifesciencecoreChannel Partner/ Reseller/ Distributor · 1 November 2023Exclusive distribution agreement covering Benelux and Spain for 3D PETG Cell Culture Scaffolds. Signed November 2023 with CEO Jordan Copner and Economy Minister Vaughan Gething.
• Cardiff Metropolitan UniversitycoreStrategic or Co-development PartnerDr Sarah E. Hooper's Microbiology & Infection Research Group using Copner Biotech's bioprinter to develop and modify in vitro chronic wound infection model.
• Swansea University (Accelerate Healthcare Technology Centre)coreStrategic or Co-development PartnerCollaborative research on efficacy of 3D PETG cell culture scaffold technology. Validation of scaffold design with fantastic cell culture results.
• Cardiff UniversitycoreStrategic or Co-development PartnerWorking with researchers at Cardiff University School of Biosciences to validate 3D PETG scaffolds for novel forms of microscopy research.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Aspect Biosystems: Canadian bioprinting company specializing in microfluidic 3D bioprinting technology for tissue engineering and regenerative medicine. Directly comparable to Copner's microfluidic droplet deposition approach and focus on user-derived bioinks for personalized tissue constructs.
• Organovo: Pioneer in 3D bioprinting of human tissues for drug discovery and therapeutic applications. Comparable to Copner in addressing limitations of 2D cell culture and animal models through bioprinted tissue constructs, though focused more on pharma drug discovery partnerships than academic research tools.
• RegenHU: Swiss manufacturer of multi-head 3D bioprinters and bioinks for tissue engineering and regenerative medicine research. Directly competes with Copner Biotech in desktop extrusion bioprinters for academic and translational research customers across Europe and globally.
• Poietis: French bioprinting company developing laser-assisted 3D bioprinting technology for tissue engineering. Comparable to Copner in serving academic research customers seeking physiologically relevant 3D tissue models, though using a different printing modality.
• Regemat 3D: Spanish bioprinter manufacturer offering extrusion-based bioprinting systems for tissue engineering and regenerative medicine research. Comparable to Copner Biotech in desktop extrusion bioprinter format and academic research customer focus, with similar revenue model of hardware sales plus bioink consumables.
• Rokit Healthcare: South Korean bioprinting company offering 3D bioprinters and bioinks for regenerative medicine and drug discovery. Comparable to Copner in providing bioprinting platforms to academic research institutions, with similar focus on personalized tissue engineering applications.

Emerging players

• CollPlant Biotechnologies: Israeli biotech developing recombinant human collagen-based bioinks for 3D bioprinting of tissues and organs. Comparable to Copner in serving the biofabrication and tissue engineering market, though focused on bioink supply rather than bioprinter hardware.

Broad incumbents

• BICO (CELLINK): Global leader in bioprinting and bioconvergence, offering a full ecosystem of 3D bioprinters (BIO X, BIO X6), bioinks, and lab automation. Most comparable to Copner Biotech in terms of core bioprinter and consumables offering for academic and pharma research customers, but with vastly greater scale, funding, and product breadth.
• Corning (Matrigel, 3D cell culture portfolio): Major life sciences supplier with extensive 3D cell culture product portfolio including scaffolds, hydrogels, and culture systems. Comparable to Copner in addressing the 2D-to-3D cell culture shift, though as a broad incumbent with established distribution and far larger product breadth.
• 3D Systems (Allevi): Acquired Allevi (formerly Advanced BioMatrix) to enter bioprinting, offering extrusion-based bioprinters and bioinks for academic and research use. Competes with Copner in desktop extrusion bioprinters for tissue engineering and 3D cell culture applications, with broader portfolio and established distribution.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/copner-biotech-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Copner Biotech